Abstract:Objective In healthy livers, latent transforming growth factor-β (LTGF-β) is stored in the extracellular matrix and kept quiescent by extracellular matrix protein 1 (ECM1). Upon damage, ECM1 is downregulated in hepatocytes, facilitating LTGF-β activation and hepatic fibrosis. This study investigates the underlying molecular mechanisms by which ECM1 expression in the liver is controlled under patho-physiological conditions. Design In silico promoter analysis was used to predict pathways that regulate Ecm1 transcription. Functional assays were performed in AML12 cells, mouse and human primary hepatocytes (MPHs, HPHs), and in liver tissue of mice and patients. Results In healthy liver, EGF/Egfr signaling maintains Ecm1 expression through phosphorylation of Stat1 at S727, which promotes its binding to the Ecm1 gene promoter to enhance gene transcription. During liver inflammation, accumulated IFNγ interferes with EGF signaling by downregulating Egfr expression and by disrupting EGF/Egfr/Stat1-mediated Ecm1 promoter binding. Mechanistically, IFNγ induces Stat1 phosphorylation at position Y701, which is competing with the ability of p-Stat1 S727 to bind to the Ecm1 gene promoter. Additionally, IFNγ induces Nrf2 nuclear translocation and repressive binding to the Ecm1 gene promoter, thus further reducing Ecm1 expression. Importantly, patients suffering from liver cirrhosis who lack nuclear NRF2 expression consistently maintain higher levels of ECM1, inferring a better prognosis. Conclusion ECM1 expression in healthy livers is controlled by EGF/EGFR/STAT1 signaling. Upon liver injury, ECM1 expression is repressed by accumulating IFNγ/NRF2, leading to increased LTGF-β activation and the onset of hepatic fibrosis. ### Competing Interest Statement The authors have declared no competing interest. * ADAMTS1 : A disintegrin and metalloproteinase with thrombospondin motifs 1 BDL : Bile duct ligation CCl4 : Carbon tetrachloride ChIP : Chromatin immunoprecipitation CLD : Chronic liver disease CYP1B1 : cytochrome P450 family 1 subfamily B member 1 ECM1 : Extracellular matrix protein 1 Ecm1- KO : Ecm1 knockout EGF : Epidermal growth factor EGFR : Epidermal growth factor receptor GEO : Gene Expression Omnibus H2O2 : Hydrogen peroxide HBV : Hepatitis-B-virus HCC : Hepatocellular carcinoma HPHs : Human primary hepatocytes HSCs : Hepatic stellate cells IFNγ : Interferon gamma i.p. : Intraperitoneal KEAP1 : Kelch-like ECH-associated protein 1 LTGF-β : Latent TGF-β MELD : Model for End-Stage Liver Disease MMP : Matrix metalloproteinase MPHs : Mouse primary hepatocytes NAFLD : Non-alcoholic fatty liver disease NASH : Non-alcoholic steatohepatitis NQO1 : NAD(P)H:quinone oxidoreductase 1 NRF2 : Nuclear factor erythroid 2-related factor 2 OPZ : Oltipraz qRT-PCR : Quantitative real-time PCR ROS : Reactive oxygen species siRNA : Small interfering RNA S727 : Serine727 TSP-1 : Thrombospondin 1 TSS : Transcription start site Y701 : Tyrosine701

Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway

SINGLE NUCLEOTIDE POLYMORPHISM IN IFN WAS ASSOCIATED WITH ACUTE REJECTION AFTER LIVER TRANSPLANTATION

Inhibition of EZH2 ameliorates bacteria-induced liver injury by repressing RUNX1 in dendritic cells

The Role of the Histone Methyltransferase EZH2 in Liver Inflammation and Fibrosis in STAM NASH Mice

Feedback loop between hepatocyte nuclear factor 1α and endoplasmic reticulum stress mitigates liver injury by downregulating hepatocyte apoptosis

LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles

Genomewide Histone H3 Lysine 9 Acetylation Profiling in Cd4+T Cells Revealed Endoplasmic Reticulum Stress Deficiency in Patients with Acute-On-Chronic Liver Failure

Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis

Role Of Histone Deacetylase Expression Levels And Activity In The Inflammatory Responses Of Patients With Chronic Hepatitis B

Integration of epigenomic and transcriptomic profiling uncovers EZH2 target genes linked to cysteine metabolism in hepatocellular carcinoma

ETS2 alleviates acute‐on‐chronic liver failure by suppressing excessive inflammation

Homocysteine facilitates endoplasmic reticulum stress and apoptosis of hepatocytes by suppressing ERO1α expression via cooperation between DNMT1 and G9a

DNMT3a-mediated methylation of TCF21/hnRNPA1 aggravates hepatic fibrosis by regulating the NF-κB signaling pathway

Human liver tissue transcriptomics revealed immunometabolic disturbances and related biomarkers in hepatitis B virus-related acute-on-chronic liver failure

Liver myofibroblasts up-regulate monocyte CD163 expression via PGE2 during hepatitis B induced liver failure

MZF1 Promotes Tumour Progression and Resistance to Anti-Pd-l1 Antibody Treatment in Hepatocellular Carcinoma

EGF/STAT1 signals to maintain ECM1 expression in hepatic homeostasis are disrupted by IFNγ/NRF2 in chronic liver disease

IGF2BP3/HIF1A/YAP signaling plays a role in driving acute-on-chronic liver failure through activating hepatocyte reprogramming

Yin Yang 1‐mediated Epigenetic Silencing of Tumour‐suppressive Micrornas Activates Nuclear Factor‐κb in Hepatocellular Carcinoma

Hepatocyte TNF Receptor-Associated Factor 6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lysine 6-Linked Polyubiquitination of Apoptosis Signal-Regulating Kinase 1

The cytoplasmic-nuclear transport of DDX3X promotes immune-mediated liver injury in mice regulated by endoplasmic reticulum stress